Mou H - Search Results

1

Understanding and repurposing CRISPR-mediated alternative splicing.

Smith JL, Mou H, Xue W. Smith JL, et al. Among authors: mou h. Genome Biol. 2018 Nov 6;19(1):184. doi: 10.1186/s13059-018-1565-3. Genome Biol. 2018. PMID: 30400804 Free PMC article.

2

A versatile reporter system for CRISPR-mediated chromosomal rearrangements.

Li Y, Park AI, Mou H, Colpan C, Bizhanova A, Akama-Garren E, Joshi N, Hendrickson EA, Feldser D, Yin H, Anderson DG, Jacks T, Weng Z, Xue W. Li Y, et al. Among authors: mou h. Genome Biol. 2015 May 28;16(1):111. doi: 10.1186/s13059-015-0680-7. Genome Biol. 2015. PMID: 26018130 Free PMC article.

3

Precision cancer mouse models through genome editing with CRISPR-Cas9.

Mou H, Kennedy Z, Anderson DG, Yin H, Xue W. Mou H, et al. Genome Med. 2015 Jun 9;7(1):53. doi: 10.1186/s13073-015-0178-7. eCollection 2015. Genome Med. 2015. PMID: 26060510 Free PMC article. Review.

4

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.

Mou H, Smith JL, Peng L, Yin H, Moore J, Zhang XO, Song CQ, Sheel A, Wu Q, Ozata DM, Li Y, Anderson DG, Emerson CP, Sontheimer EJ, Moore MJ, Weng Z, Xue W. Mou H, et al. Genome Biol. 2017 Jun 14;18(1):108. doi: 10.1186/s13059-017-1237-8. Genome Biol. 2017. PMID: 28615073 Free PMC article.

5

CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.

Mou H, Ozata DM, Smith JL, Sheel A, Kwan SY, Hough S, Kucukural A, Kennedy Z, Cao Y, Xue W. Mou H, et al. Genome Med. 2019 Apr 16;11(1):21. doi: 10.1186/s13073-019-0627-9. Genome Med. 2019. PMID: 30987660 Free PMC article.

6

Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins.

Lee J, Mou H, Ibraheim R, Liang SQ, Liu P, Xue W, Sontheimer EJ. Lee J, et al. Among authors: mou h. RNA. 2019 Nov;25(11):1421-1431. doi: 10.1261/rna.071704.119. Epub 2019 Aug 22. RNA. 2019. PMID: 31439808 Free PMC article.

7

Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.

Wang D, Mou H, Li S, Li Y, Hough S, Tran K, Li J, Yin H, Anderson DG, Sontheimer EJ, Weng Z, Gao G, Xue W. Wang D, et al. Among authors: mou h. Hum Gene Ther. 2015 Jul;26(7):432-42. doi: 10.1089/hum.2015.087. Hum Gene Ther. 2015. PMID: 26086867 Free PMC article.

8

Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.

Song CQ, Li Y, Mou H, Moore J, Park A, Pomyen Y, Hough S, Kennedy Z, Fischer A, Yin H, Anderson DG, Conte D Jr, Zender L, Wang XW, Thorgeirsson S, Weng Z, Xue W. Song CQ, et al. Among authors: mou h. Gastroenterology. 2017 Apr;152(5):1161-1173.e1. doi: 10.1053/j.gastro.2016.12.002. Epub 2016 Dec 10. Gastroenterology. 2017. PMID: 27956228 Free PMC article.

9

Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.

Mou H, Moore J, Malonia SK, Li Y, Ozata DM, Hough S, Song CQ, Smith JL, Fischer A, Weng Z, Green MR, Xue W. Mou H, et al. Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3648-3653. doi: 10.1073/pnas.1620861114. Epub 2017 Mar 20. Proc Natl Acad Sci U S A. 2017. PMID: 28320962 Free PMC article.

10

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.

Yin H, Song CQ, Suresh S, Wu Q, Walsh S, Rhym LH, Mintzer E, Bolukbasi MF, Zhu LJ, Kauffman K, Mou H, Oberholzer A, Ding J, Kwan SY, Bogorad RL, Zatsepin T, Koteliansky V, Wolfe SA, Xue W, Langer R, Anderson DG. Yin H, et al. Among authors: mou h. Nat Biotechnol. 2017 Dec;35(12):1179-1187. doi: 10.1038/nbt.4005. Epub 2017 Nov 13. Nat Biotechnol. 2017. PMID: 29131148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page